Heilongjiang Zbd Pharmaceutical Co., Ltd. Class ASSE: 603567

"Heilongjiang ZBD Pharmaceutical Co., Ltd."Notice on Convening the 3rd Extraordinary General Meeting in 2026

Jul 15, 2026 · Issued by Heilongjiang Zbd Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Notice on Convening the 3rd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Heilongjiang Zbd Pharmaceutical Co., Ltd. Class A

"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Implementation of Repurchase and Cancellation of Partial Restricted Stocks under 2023 Restricted Stock Incentive PlanJul 14
"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Partial Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual ReportJul 9

All Heilongjiang Zbd Pharmaceutical Co., Ltd. Class A news releases